How to manage Covid 2.0
1/2
2/2
×
As far as possible a lockdown should not be reimposed but a strong decentralised system of healthcare must be built
Experts in India and elsewhere are not sure when the Covid pandemic is likely to peak. As saving lives and preventing possible economic disaster are critical now, achieving 11 per cent growth in the the current year has become a peripheral issue. The sustainability of the current medi-care and support systems is being challenged by non-availability of critical drugs and equipment, besides the deteriorating finances and diminished revenue collections of State governments.
The key concern for the next couple of months is saving human life. Even as the pandemic enters the second wave, posing a risk to millions, healthcare services remain inadequate and unsatisfactory. Also, the threat is equally serious for people not having enough purchasing power to buy food and other essentials for survival; only 15 per cent of the country’s w
Covid 2.0: Curfews, partial lockdowns threaten India’s economic recovery
Covid 2.0: Curfews, partial lockdowns threaten India’s economic recovery
Night curfews and weekend lockdowns imposed by various state governments pose a threat to India s economic recovery. Malls, showrooms and branded shops across the country are largely empty due to government restrictions.
advertisement
UPDATED: April 17, 2021 16:26 IST
Delhi Chief Minister Arvind Kejriwal on Thursday announced a weekend curfew in the national capital. The weekend curfew will be enforced from 10 pm on Friday till 6 am Monday. (PTI)
The Indian economy, which was recovering at a snail’s pace, has been hit by the rising number of Covid-19 cases across states and subsequent curfews/lockdowns imposed by various state governments.
Explore Now
NEW DELHI: From a market price of Rs 2,250 at the end of January to a record high of Rs 3,398.95 on Monday, shares of Dr Lal Pathlabs have rallied 51 per cent in just two months. Following this strong rally, a host of brokerages have turned cautious on the stock, with some predicting that a big fall in the stock may be imminent.
The latest brokerage to give such a call is Nomura, which on Tuesday downgraded Dr Lal Pathlabs to ‘reduce’ rating with a price target of Rs 2,333, marking a 30 per cent downside. The stock fell almost 12 per cent for the day.
ET Markets RadioTune in now for Markets news, views & cues
ETMarkets Investors Guide (ETMarkets.com)
13:44 Min | April 11, 2021, 3:51 PM IST
We dig deeper on the outlook for banking stocks amid Covid 2.0. Listen in.
Tags
Transcript
Hello, you have tuned into ETMarkets Investors Guide, a show about asset classes, investment ideas and market trends. I am Nikhil Agarwal.
As investors lap up stocks from defensive sectors like IT, pharma and FMCG, besides metals, in a choppy market, financials seem to be losing their charm. Investors fear the second wave of Covid may worsen the outlook for banks. Bank Nifty lost 4 per cent in value terms last week and is down over 9 per cent on a monthly basis. Metals, on the other hand, continue to mint money for investors.
Dan Haar: Hope amid chaos for CT s first vaccinated couple
FacebookTwitterEmail
1of3
Ewelina and Dr. Michelle McDade, who both work for Hartford HealthCare were the first married couple to receive the COVID-19 vaccine. Ewelina, shown being inoculated in her left arm on Dec. 14, is manager of nursing education at the Hospital of Central Connecticut in New Britain, Bradley Memorial in Southington and Mid-State Medical Center in Meriden, and a former ER nurse. Michelle, shown in a print shirt getting a shot in her right arm, is associate chief of emergency medicine at Hospital of Central Connecticut.Curtesy of Michelle and Ewelina McDadeShow MoreShow Less